s6y Gritstone bio, Inc. 10-K

Gritstone bio, Inc. 10-K, filed Mar 10, 2022: IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Reconciliation of the Statutory Federal Income Tax Rate to the Company's Effective Tax Rate (Detail)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Statutory federal income tax rate 21.00% 21.00% 21.00%
State tax, net of federal benefit 10.20% 7.90% 4.20%
Permanent differences (0.10%) (0.60%) (0.80%)
Research and development tax credits 1.90% 2.80% 2.60%
Other (1.80%) (0.20%) (0.80%)
Change in state tax apportionment 0.00% 9.40% 0.00%
Non-taxable stock premium 2.50% 0.00% 0.00%
Change in valuation allowance (33.70%) (40.30%) (26.30%)
Total provision for income taxes 0.00% 0.00% 0.00%